• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » SLAS expands global operations with Brussels office

SLAS expands global operations with Brussels office

September 4, 2013
CenterWatch Staff

The Society for Laboratory Automation and Screening (SLAS), an international community of more than 15,000 individual scientists, engineers, researchers and technologists from academic, government and commercial laboratories, has opened a European office in Brussels, Belgium. The SLAS Europe office becomes the Society’s third on three different continents, joining operations in Shanghai, China, and SLAS global headquarters in Chicago.

The Europe office is part of the SLAS Strategic Plan. Approximately 20% of SLAS’ global membership is based in Europe. To better serve these constituents, SLAS commissioned an extensive market research study in 2012 that indicated its European members held the Society in positive regard and were interested in taking advantage of its product and services offerings, especially if they were customized to European audiences and priority needs. The goal is to grow European membership and engagement levels.

“We take another major step toward fulfilling our commitment to enabling laboratory science and technology professionals around the globe to enjoy increased access to our full menu of programs, products, services and events,” said Jeff Paslay, SLAS president. “Our new SLAS Europe office is an essential first step in amplifying European participation to the 360-degrees of benefits available to SLAS members everywhere.”

Staffed by a team of three professionals, the short-term objectives for the SLAS European team include establishment of a Europe volunteer leadership team. Another priority is building alliances with complementary, mission-driven organizations that also serve the scientific technology professional community.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing